Tamm-Horsfall glycoprotein (THG) purified from normal human pregnancy urine increases phagocytosis, complement receptor expressions and arachidonic acid metabolism of polymorphonuclear neutrophils.
Tamm-Horsfall glycoprotein (THG) purified from normal human pregnancy urine was found to increase polymorphonuclear neutrophil (PMN) phagocytosis (46.57 +/- 3.54% in the medium versus 75.85 +/- 5.37% in the presence of 25 micrograms/ml THG) after 30 min preincubation. The phagocytosis-enhancing activity of THG was dose-dependent (5-50 micrograms/ml) and was possibly mediated by the increased expressions of complement receptor type 1 (CR1) and type 3 (CR3) on the neutrophils. The release of [3H]arachidonic acid and prostaglandin E2 (PGE2), but not thromboxane B2 (TXB2), from neutrophils were also significantly enhanced by THG. Using 3,3'-dihexyloxacarbocyanine iodide as indicator, THG (25 micrograms/ml) depolarized the membrane potential of PMN after 30 min preincubation. In addition, THG exhibited a specific membranotropic effect with PMN. It is conceivable that THG binds to the cell surface and depolarizes the membrane potential of PMN which subsequently enhances the release of arachidonic acid metabolites and the translocation of the complement receptors to the membrane. These biochemical events lead to the increment of PMN phagocytosis and suggests that THG may play an important role in the defense mechanisms of the urinary tract in that a large amount of THG is usually present.
Yu
C L
CL
Department of Medicine, Veterans General Hospital, Taipei, Taiwan, ROC.
Lin
W M
WM
Liao
T S
TS
Tsai
C Y
CY
Sun
K H
KH
Chen
K H
KH
D016718:Arachidonic Acid / Q000378:metabolism*; D001665:Binding Sites; D015232:Dinoprostone / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016177:Macrophage-1 Antigen / Q000096:biosynthesis; D008564:Membrane Potentials / Q000187:drug effects; D009088:Mucoproteins / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology* / Q000652:urine; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects*; D011247:Pregnancy; D011951:Receptors, Complement / Q000096:biosynthesis*; D013929:Thromboxane B2 / Q000378:metabolism; D058949:Uromodulin
D016177:Macrophage-1 Antigen; D009088:Mucoproteins; D011951:Receptors, Complement; C548612:UMOD protein, human; D058949:Uromodulin; D016718:Arachidonic Acid; D013929:Thromboxane B2; D015232:Dinoprostone